The challenges of virtual wards and matching hospital-level care
Like any new initiative, widespread implementation of virtual wards brings to light a number of challenges, particularly when trying to establish the level of care matching that of a hospital in-patient. Accurate and frequent patient monitoring is essential to support clinical decision-making. Early detection of any deterioration in patients’ conditions enables ly in-person medical intervention while accommodating for clinician travel time to the patient. Furthermore, secure and user-friendly systems must be in place to handle sensitive information properly and to communicate monitoring results effectively to patients. Ensuring the necessary technology is available to facilitate these processes is crucial for supporting responsive and timely decision-making.
Diagnostics
PoC and self-testing diagnostics are crucial for virtual wards, providing timely information for home patient management. However, the shift towards decentralised and self-administered testing presents a number of challenges. Ensuring usability for non-specialist users, maintaining patient engagement and integrating seamlessly with existing healthcare systems are vital to maximising the impact of these innovations.
Examples of some of the innovations in diagnostics tools are Abbott’s i-STAT, which brought essential blood chemistry and haematology testing to the bedside, gaining traction in emergency departments and intensive care units for its speed and portability. Launched in 2014, LumiraDx’s microfluidic technology advances rapid testing of inflammation markers (CRP) and coagulation metrics (INR, D-Dimer) from a simple finger-prick sample, making it ideal for decentralised care settings like virtual wards and particularly suited for non-specialist users.
While some tests still require a care professional, there are options for self-administration or continuous monitoring. Capillary Blood Glucose (CBG) testing is a prime example of this evolution. In the 1960s, bedside blood sugar testing allowed clinicians to make timely decisions for critically ill diabetic patients. The 1980s saw the commercialisation of self-administered finger-prick tests, which were smaller, cheaper and more accurate. This frequent monitoring empowered patients to manage their glucose levels independently. One of the latest areas seeing a revolution is body-worn Continuous Glucose Monitors (CGM) like Freestyle Libre and Dexcom, providing real-time readings and eliminating the need for routine manual finger-pricks.
Testing technology needs to be distributed to bring it closer to patients, avoiding the time and cost of moving equipment and samples. Near-patient Testing (NPT) is crucial for virtual wards’ cost-effectiveness. For instance, in a virtual respiratory ward, NPT devices can monitor inflammation markers to detect worsening conditions and enable timely interventions. A UK pilot study showed that NPT for inflammation markers reduced follow-up visits and improved safety, saving up to £3,914 per patient.
The evolution of PoC testing reflects a shift from centralised, professional-driven testing to personalised, real-time and non-invasive monitoring. Each phase enhances condition management, patient autonomy and quality of life, with wearable and non-invasive technologies promising to take this journey even further. However, integrating technology into daily life brings an explosion of information and therefore can present challenges. Usability, patient engagement and seamless healthcare system integration must be addressed to maximise these innovations’ impact.